.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Covington
UBS
Novartis
Citi
Healthtrust
Deloitte
Cerilliant
Farmers Insurance
McKesson

Generated: June 27, 2017

DrugPatentWatch Database Preview

Details for Biologics License Application 103772

« Back to Dashboard

Summary for BLA: 103772

Tradename:
REMICADE
Applicant:
Centocor Inc
Ingredient:
infliximab
Patents:249
Approval Date:Aug 24, 1998
Suppliers: see list1

Pharmacology for BLA: 103772

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Inventors Patent Expiration Status Orphan Source
Centocor Inc
REMICADE
infliximab
VIAL1037720011998-08-246,015,557 Tobinick; Edward L. (Los Angeles, CA), Tobinick; Arthur Jerome (Los Angeles, CA) ► SubscribeRXOrphansearch
Centocor Inc
REMICADE
infliximab
VIAL1037720011998-08-246,177,077 Tobinick; Edward L. (Los Angeles, CA) ► SubscribeRXOrphansearch
Centocor Inc
REMICADE
infliximab
VIAL1037720011998-08-246,362,213 ICOS Corporation (Bothell, WA) Gaudino; John J. (Boulder, CO) ► SubscribeRXOrphansearch
Centocor Inc
REMICADE
infliximab
VIAL1037720011998-08-246,379,666 Tobinick; Edward L. (Los Angeles, CA) ► SubscribeRXOrphansearch
Centocor Inc
REMICADE
infliximab
VIAL1037720011998-08-246,419,934 Tobinick; Edward L. (Los Angeles, CA) ► SubscribeRXOrphansearch
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Daiichi Sankyo
QuintilesIMS
Medtronic
Deloitte
Merck
AstraZeneca
Johnson and Johnson
Queensland Health
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot